4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000905718-17-000813
Director sold 22,781 shares at an average $19.42 ($442,403)
From the SEC's structured data for this filing
Trades in this filing
EMSTER KURT VON · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2017-08-24 | Sale : show line 1 in the form | −7,868 | $19.23 | $151,302 | 2,054,283 | I |
| 2017-08-25 | Sale : show line 2 in the form | −14,913 | $19.52 | $291,102 | 2,039,370 | I |
| Open-market sales · 22,781 sh · avg $19.42 · $442,403 | ||||||
Loading xslF345X03/vonemster_fm4aug242017.xml…